AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
Medical Device Network on MSN

AliveCor secures FDA approval for next-generation Kardia 12L ECG system

The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
Medical Device and Diagnostic Industry (MD+DI)

AliveCor’s Tumultuous Week

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...
MassDevice

AliveCor earns another FDA nod for AI-powered 12-lead ECG tech

AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
Medscape

ECG Challenge: Cardiac Abnormalities After Aortic Valve Replacement

The correct diagnosis is sinus tachycardia, left atrial abnormality, and QRS (electrical) alternans, right axis caused by left posterior fascicular block (Figure 2). The rhythm is regular at a rate of ...
Business Wire

Cardiac Insight Reports Increased Cardea 20/20 ECG™ Sales to Screen Young Athletes for Conditions at Risk for Sudden Cardiac Arrest

BELLEVUE, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a healthcare innovator specializing in wearable electrocardiogram (ECG) cardiac sensors and proven automated ECG analysis that delivers ...
Open Heart

Severe aortic stenosis detection using seismocardiography

Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...